Non-genomic Effects of Nuclear Receptors: Insights from the Anucleate Platelet

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2018 Feb 17

PMID 29452349

Citations 23

Authors

Amanda J Unsworth

Gagan D Flora

Jonathan M Gibbins

Affiliations

Soon will be listed here.

Abstract

Nuclear receptors (NRs) have the ability to elicit two different kinds of responses, genomic and non-genomic. Although genomic responses control gene expression by influencing the rate of transcription, non-genomic effects occur rapidly and independently of transcriptional regulation. Due to their anucleate nature and mechanistically well-characterized and rapid responses, platelets provide a model system for the study of any non-genomic effects of the NRs. Several NRs have been found to be present in human platelets, and multiple NR agonists have been shown to elicit anti-platelet effects by a variety of mechanisms. The non-genomic functions of NRs vary, including the regulation of kinase and phosphatase activity, ion channel function, intracellular calcium levels, and production of second messengers. Recently, the characterization of mechanisms and identification of novel binding partners of NRs have further strengthened the prospects of developing their ligands into potential therapeutics that offer cardio-protective properties in addition to their other defined genomic effects.

Citing Articles

The Cortisol Effect on the NO/cGMP Pathway.

Signorello M, Leoncini G Int J Mol Sci. 2025; 26(4).

PMID: 40003888 PMC: 11855650. DOI: 10.3390/ijms26041421.

Activation of the Coagulation Cascade as a Universal Danger Sign.

Starikova E, Mammedova J, Rubinstein A, Sokolov A, Kudryavtsev I Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996829 PMC: 11854423. DOI: 10.3390/cimb47020108.

Oxidative Stress Induced by Cortisol in Human Platelets.

Signorello M, Ravera S, Leoncini G Int J Mol Sci. 2024; 25(7).

PMID: 38612585 PMC: 11011787. DOI: 10.3390/ijms25073776.

Non-canonical non-genomic morphogen signaling in anucleate platelets: a critical determinant of prothrombotic function in circulation.

Kulkarni P, Ekhlak M, Dash D Cell Commun Signal. 2024; 22(1):13.

PMID: 38172855 PMC: 10763172. DOI: 10.1186/s12964-023-01448-y.

Fenofibrate reduces glucose-induced barrier dysfunction in feline enteroids.

Crawford C, Beltran A, Castillo D, Matloob M, Uehara M, Quilici M Sci Rep. 2023; 13(1):22558.

PMID: 38110453 PMC: 10728136. DOI: 10.1038/s41598-023-49874-9.

References

Walmsley S, Northfelt D, Melosky B, Conant M, Friedman-Kien A, Wagner B . Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. J Acquir Immune Defic Syndr. 2000; 22(3):235-46. DOI: 10.1097/00126334-199911010-00004. View

Losel R, Falkenstein E, Feuring M, Schultz A, Tillmann H, Rossol-Haseroth K . Nongenomic steroid action: controversies, questions, and answers. Physiol Rev. 2003; 83(3):965-1016. DOI: 10.1152/physrev.00003.2003. View

Schulz C, Massberg S . Platelets in atherosclerosis and thrombosis. Handb Exp Pharmacol. 2012; (210):111-33. DOI: 10.1007/978-3-642-29423-5_5. View

Ali F, Hall M, Desvergne B, Warner T, Mitchell J . PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report. Arterioscler Thromb Vasc Biol. 2009; 29(11):1871-3. DOI: 10.1161/ATVBAHA.109.193367. View

Khetawat G, Faraday N, Nealen M, Vijayan K, Bolton E, Noga S . Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Blood. 2000; 95(7):2289-96. View

Sundahl N, Bridelance J, Libert C, De Bosscher K, Beck I . Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds. Pharmacol Ther. 2015; 152:28-41. DOI: 10.1016/j.pharmthera.2015.05.001. View

Nathan A, Sen S, Yeh R . The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease. Expert Opin Drug Saf. 2017; 16(5):561-572. DOI: 10.1080/14740338.2017.1315101. View

Moraes L, Piqueras L, Bishop-Bailey D . Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther. 2005; 110(3):371-85. DOI: 10.1016/j.pharmthera.2005.08.007. View

Overington J, Al-Lazikani B, Hopkins A . How many drug targets are there?. Nat Rev Drug Discov. 2006; 5(12):993-6. DOI: 10.1038/nrd2199. View

10.

Ahmadian M, Suh J, Hah N, Liddle C, Atkins A, Downes M . PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013; 19(5):557-66. PMC: 3870016. DOI: 10.1038/nm.3159. View

11.

Murphy E . Estrogen signaling and cardiovascular disease. Circ Res. 2011; 109(6):687-96. PMC: 3398381. DOI: 10.1161/CIRCRESAHA.110.236687. View

12.

Wu-Wong J . Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol. 2009; 158(2):395-412. PMC: 2757680. DOI: 10.1111/j.1476-5381.2009.00171.x. View

13.

Risitano A, Beaulieu L, Vitseva O, Freedman J . Platelets and platelet-like particles mediate intercellular RNA transfer. Blood. 2012; 119(26):6288-95. PMC: 3383198. DOI: 10.1182/blood-2011-12-396440. View

14.

Gabbi C, Warner M, Gustafsson J . Action mechanisms of Liver X Receptors. Biochem Biophys Res Commun. 2013; 446(3):647-50. DOI: 10.1016/j.bbrc.2013.11.077. View

15.

Bain D, Heneghan A, Connaghan-Jones K, Miura M . Nuclear receptor structure: implications for function. Annu Rev Physiol. 2006; 69:201-20. DOI: 10.1146/annurev.physiol.69.031905.160308. View

16.

Ng H, Perkins R, Tong W, Hong H . Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands. Int J Environ Res Public Health. 2014; 11(9):8709-42. PMC: 4198987. DOI: 10.3390/ijerph110908709. View

17.

Campelo A, Cutini P, Massheimer V . Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway. J Endocrinol. 2012; 213(1):77-87. DOI: 10.1530/JOE-11-0441. View

18.

Akarasereenont P, Tripatara P, Chotewuttakorn S, Palo T, Thaworn A . The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate. Platelets. 2006; 17(7):441-7. DOI: 10.1080/09537100600745302. View

19.

Spyridon M, Moraes L, Jones C, Sage T, Sasikumar P, Bucci G . LXR as a novel antithrombotic target. Blood. 2011; 117(21):5751-61. PMC: 3110032. DOI: 10.1182/blood-2010-09-306142. View

20.

Kersten S, Desvergne B, Wahli W . Roles of PPARs in health and disease. Nature. 2000; 405(6785):421-4. DOI: 10.1038/35013000. View